These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 10897592

  • 21. Effect of strict blood pressure control on proteinuria in renal patients treated with different antihypertensive drugs.
    García de Vinuesa S, Luño J, Gómez-Campderá F, Ridao N, Sánchez M, Dall'Anese C, Valderrábano F.
    Nephrol Dial Transplant; 2001; 16 Suppl 1():78-81. PubMed ID: 11369828
    [Abstract] [Full Text] [Related]

  • 22. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
    Tytus RH, Burgess ED, Assouline L, Vanjaka A.
    Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
    [Abstract] [Full Text] [Related]

  • 23. [Renal hemodynamics and proteinuria in chronic glomerulonephritis treated with beta-receptor blockers or ace inhibitors].
    Erley CM, Berger ED, Heyne N, Klass M, Krämer D, Braun N, Wolf S, Risler T.
    Dtsch Med Wochenschr; 1997 Aug 01; 122(31-32):953-8. PubMed ID: 9280714
    [Abstract] [Full Text] [Related]

  • 24. Angiotensin-converting-enzyme inhibitors slow renal decline in IgA nephropathy, independent of tubulointerstitial fibrosis at presentation.
    Kanno Y, Okada H, Yamaji Y, Nakazato Y, Suzuki H.
    QJM; 2005 Mar 01; 98(3):199-203. PubMed ID: 15728401
    [Abstract] [Full Text] [Related]

  • 25. Effects of angiotensin converting enzyme inhibitor on renal function in patients of membranoproliferative glomerulonephritis with mild to moderate renal insufficiency.
    Giri S, Mahajan SK, Sen R, Sharma A.
    J Assoc Physicians India; 2002 Oct 01; 50():1245-9. PubMed ID: 12568207
    [Abstract] [Full Text] [Related]

  • 26. Safety and efficacy of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in chronic allograft injury.
    Shah PR, Kute VB, Saboo DS, Goplani KR, Gumber MR, Vanikar AV, Patel HV, Trivedi HL.
    Saudi J Kidney Dis Transpl; 2011 Nov 01; 22(6):1128-32. PubMed ID: 22089769
    [Abstract] [Full Text] [Related]

  • 27. Does the hyperfiltration of minoxidil result in increased proteinuria and loss of renoprotection conferred by angiotensin inhibition?
    Diskin CJ, Stokes TJ, Dansby LM, Radcliff L, Carter TB.
    Kidney Blood Press Res; 2006 Nov 01; 29(1):54-9. PubMed ID: 16645303
    [Abstract] [Full Text] [Related]

  • 28. Fractional urinary excretion of IgG is the most powerful predictor of renoprotection by ACE inhibitors in IgA nephropathy.
    Bazzi C, Rizza V, Paparella M, Casellato D, Napodano P, Olivieri G, D'Amico G.
    J Nephrol; 2009 Nov 01; 22(3):387-96. PubMed ID: 19557716
    [Abstract] [Full Text] [Related]

  • 29. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H, Kanno Y, Nakamoto H, Okada H, Sugahara S.
    Clin Exp Hypertens; 2005 Nov 01; 27(2-3):129-38. PubMed ID: 15835375
    [Abstract] [Full Text] [Related]

  • 30. Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury.
    Zoja C, Corna D, Bruzzi I, Foglieni C, Bertani T, Remuzzi G, Benigni A.
    Exp Nephrol; 1996 Nov 01; 4(4):213-21. PubMed ID: 8983642
    [Abstract] [Full Text] [Related]

  • 31. Long-term effect of antihypertensive therapy with calcium antagonist or angiotensin converting enzyme inhibitor on serum nitrite/nitrate levels in human essential hypertension.
    Takase H, Sugiyama M, Nakazawa A, Sato K, Ueda R, Dohi Y.
    Arzneimittelforschung; 2000 Jun 01; 50(6):530-4. PubMed ID: 10918945
    [Abstract] [Full Text] [Related]

  • 32. Effect of the angiotensin converting enzyme inhibitor, captopril, on proteinuria in chronic glomerular disease.
    Masunaga Y, Tabei K, Takeda S, Ando Y, Kusano E, Asano Y.
    Nihon Jinzo Gakkai Shi; 1993 Aug 01; 35(8):961-6. PubMed ID: 8255007
    [Abstract] [Full Text] [Related]

  • 33. ACEI/ATRA therapy decreases proteinuria by improving glomerular permselectivity in IgA nephritis.
    Woo KT, Lau YK, Wong KS, Chiang GS.
    Kidney Int; 2000 Dec 01; 58(6):2485-91. PubMed ID: 11115082
    [Abstract] [Full Text] [Related]

  • 34. Antiproteinuric efficacy of verapamil in comparison to trandolapril in non-diabetic renal disease.
    Hemmelder MH, de Zeeuw D, de Jong PE.
    Nephrol Dial Transplant; 1999 Jan 01; 14(1):98-104. PubMed ID: 10052485
    [Abstract] [Full Text] [Related]

  • 35. [The effect of blood pressure control on the progression of chronic glomerulonephritis associated with hypertension].
    Arima S, Abe K, Kudo K, Tsunoda K, Yabe T, Imai Y, Saito T, Sato H, Yoshinaga K.
    Nihon Jinzo Gakkai Shi; 1991 Jun 01; 33(6):597-604. PubMed ID: 1920940
    [Abstract] [Full Text] [Related]

  • 36. [Factors in the progression of renal insufficiency during the 2 years preceding the use of dialysis].
    Kacso I, Gherman M, Mazouz H, Ghazali A, el Esper N, Morinière P, Makdassi R, Hardy P, Westeel PF, Achard JM, Pruna A, Fournier A.
    Nephrologie; 1999 Jun 01; 20(1):19-28. PubMed ID: 10081033
    [Abstract] [Full Text] [Related]

  • 37. Dissociation between blood pressure reduction and fall in proteinuria in primary renal disease: a randomized double-blind trial.
    PROCOPA Study Group.
    J Hypertens; 2002 Apr 01; 20(4):729-37. PubMed ID: 11910310
    [Abstract] [Full Text] [Related]

  • 38. Amlodipine is comparable to angiotensin-converting enzyme inhibitor for long-term renoprotection in hypertensive patients with renal dysfunction: a one-year, prospective, randomized study.
    Kumagai H, Hayashi K, Kumamaru H, Saruta T.
    Am J Hypertens; 2000 Sep 01; 13(9):980-5. PubMed ID: 10981547
    [Abstract] [Full Text] [Related]

  • 39. [Comparison of ARB and ACEI for renoprotection in chronic glomerulonephritis].
    Kumagai H, Sakata K, Matsuura T, Imai M, Onami T, Iigaya K, Saruta T.
    Nihon Rinsho; 2002 Oct 01; 60(10):2005-13. PubMed ID: 12397699
    [Abstract] [Full Text] [Related]

  • 40. Long-term benefits of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin a nephropathy: a comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapy.
    Cattran DC, Greenwood C, Ritchie S.
    Am J Kidney Dis; 1994 Feb 01; 23(2):247-54. PubMed ID: 8311083
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.